ArticlebioRxiv : the preprint server for biology2023
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Na Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.